Order Article Reprints

Constantinescu C, Pasca S, Zimta A-A, Tat T, Rus I, Teodorescu P, Iluta S, Tanase A, Colita A, Sigurjonsson O, et al. Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies. Journal of Clinical Medicine. 2020; 9(9):2903. https://doi.org/10.3390/jcm9092903

Constantinescu, Catalin, Sergiu Pasca, Alina-Andreea Zimta, Tiberiu Tat, Ioana Rus, Patric Teodorescu, Sabina Iluta, Alina Tanase, Anca Colita, Olafur Sigurjonsson, and et al. 2020. "Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies" Journal of Clinical Medicine 9, no. 9: 2903. https://doi.org/10.3390/jcm9092903

Constantinescu, C., Pasca, S., Zimta, A.-A., Tat, T., Rus, I., Teodorescu, P., Iluta, S., Tanase, A., Colita, A., Sigurjonsson, O., Einsele, H., & Tomuleasa, C. (2020). Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies. Journal of Clinical Medicine, 9(9), 2903. https://doi.org/10.3390/jcm9092903